Page last updated: 2024-08-24

gemcitabine and Wasting Disease

gemcitabine has been researched along with Wasting Disease in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bekaii-Saab, T; Chen, CS; Ding, LY; Henderson, SE; Huang, PH; Kulp, SK; Mo, X	1

Other Studies

1 other study(ies) available for gemcitabine and Wasting Disease

Article	Year
Suppression of Tumor Growth and Muscle Wasting in a Transgenic Mouse Model of Pancreatic Cancer by the Novel Histone Deacetylase Inhibitor AR-42. Neoplasia (New York, N.Y.), 2016, Volume: 18, Issue:12 Topics: Animals; Cell Cycle; Cell Line, Tumor; Cell Survival; Deoxycytidine; Disease Models, Animal; Drug Synergism; Female; Gemcitabine; Histone Deacetylase Inhibitors; Humans; Kaplan-Meier Estimate; Mice, Transgenic; Muscle, Skeletal; Pancreatic Neoplasms; Phenylbutyrates; Tumor Burden; Wasting Syndrome; Xenograft Model Antitumor Assays	2016

Article

Year

Suppression of Tumor Growth and Muscle Wasting in a Transgenic Mouse Model of Pancreatic Cancer by the Novel Histone Deacetylase Inhibitor AR-42.

Neoplasia (New York, N.Y.), 2016, Volume: 18, Issue:12

Topics: Animals; Cell Cycle; Cell Line, Tumor; Cell Survival; Deoxycytidine; Disease Models, Animal; Drug Synergism; Female; Gemcitabine; Histone Deacetylase Inhibitors; Humans; Kaplan-Meier Estimate; Mice, Transgenic; Muscle, Skeletal; Pancreatic Neoplasms; Phenylbutyrates; Tumor Burden; Wasting Syndrome; Xenograft Model Antitumor Assays

2016